Home/Filings/4/0001127602-23-014610
4//SEC Filing

Louie Linda H. 4

Accession 0001127602-23-014610

CIK 0000318154other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 8:30 PM ET

Size

9.5 KB

Accession

0001127602-23-014610

Insider Transaction Report

Form 4
Period: 2023-05-02
Louie Linda H.
VP, Finance & CAO
Transactions
  • Award

    Nqso (Right to Buy)

    2023-05-02+3,5833,583 total
    Exercise: $235.97From: 2025-05-02Exp: 2033-05-02Common Stock (3,583 underlying)
  • Award

    Common Stock

    2023-05-02+42310,002 total
  • Tax Payment

    Common Stock

    2023-05-02$235.97/sh20$4,7199,982 total
Footnotes (4)
  • [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/2/2025, 5/2/2026 and 5/2/2027, respectively.
  • [F2]These shares include the following RSUs granted under the Company's equity plans: 114 RSUs which will vest in installments of 56 on 5/5/2023 and 58 on 5/5/2024; 974 RSUs which will vest in installments of 479 on 11/2/2023 and 495 on 11/2/2024; 201 RSUs which will vest in installments of 99 on 4/30/2024 and 102 on 4/30/2025; 175 RSUs which will vest on 11/5/2023; 433 RSUs which will vest in installments of 142 on 5/2/2024, 143 on 5/2/2025, and 148 on 5/5/2026; and 423 RSUs which will vest in installments of 139 on 5/2/2025, 140 on 5/2/2026 and 144 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F3]These shares include 127 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
  • [F4]These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/2/2025, 5/2/2026 and 5/2/2027, respectively.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001818953

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 8:30 PM ET
Size
9.5 KB